Vancouver, British Columbia–(Newsfile Corp. – February 3, 2025) – Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) (“Beyond Medical” or the “Company“) is pleased to announce that it has appointed Daniel Liu as Chief Executive Officer and as a director of the Company. Mr. Liu replaces Kal Malhi in these roles, following Mr. Malhi’s resignation as Chief Executive Officer and as a director, effective January 30, 2025.
Mr Malhi leaves Beyond Medical to pursue other ventures but will remain available to consult for the Company as required. The Company would like to thank Mr. Malhi for his service and wishes him the best in his future endeavors.
On behalf of the Board of Directors
“Daniel Liu” Chief Executive Officer
Email: danzliu94@gmail.com
https://beyond-md.ca/
Neither the Canadian Securities Exchange nor its Regulation Services Provider has reviewed or accepts responsibility for the accuracy or adequacy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/239500
Guests had an opportunity to meet Gabby Thomas, win health-focused prizes, and learn simple ways…
NEW YORK CITY, NY / ACCESS Newswire / January 10, 2026 / The phrase best…
CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…
Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…
Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…
Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…